Trade in medicinal products within the Community is hindered by disparities between certain national provisions, in particular between provisions relating to medicinal products (excluding substances or combinations of substances which are foods, animal feeding-stuffs or toilet preparations), and such disparities directly affect the functioning of the internal market.
Recital 4, Directive (EU) 2001/83
The 10 that are cited most themselves, of 18.
Judgment of the Court (Second Chamber) of 8 November 2007. Gintec International Import-Export GmbH v Verband Sozialer Wettbewerb eV.Decision
In that regard, it is necessary to point out that Directive 2001/83 was adopted on the basis of Article 95 EC, which, in paragraph 1, permits, by way of derogation from Article 94 EC and save where otherwise provided in the EC Treaty, the …
8 Nov 2007 · 62005CJ0374
Judgment of the Court (First Chamber) of 15 November 2007. Commission of the European Communities v Federal Republic of Germany.Decision
The second to the fifth recitals in the preamble to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67) state: The …
15 Nov 2007 · 62005CJ0319
Judgment of the Court (First Chamber) of 20 September 2007. Staat der Nederlanden v Antroposana, Patiëntenvereniging voor Antroposofische GeDecision
According to the second, fourth and fifth recitals in the preamble thereto, the purpose of Directive 2001/83 is to ‘safeguard public health’ and to eliminate hindrances to ‘trade in medicinal products within the Community’.
20 Sep 2007 · 62006CJ0084
Judgment of the Court (Second Chamber), 28 June 2012. Fabio Caronna.Decision
Recitals 2 to 5 and 35 and 36 of the Directive are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be …
28 Jun 2012 · 62011CJ0007
Judgment of the Court (Third Chamber) of 11 June 2020. ratiopharm GmbH v Novartis Consumer Health GmbH.Decision
Recitals 2 to 4, 14, 45 to 47, 50 and 51 of Directive 2001/83 are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this …
11 Jun 2020 · 62018CJ0786
Judgment of the Court (First Chamber) of 18 June 2009. The Queen, on the application of Generics (UK) Ltd v Licensing Authority.Decision
Recitals 2, 4, 5 and 10 in the preamble to Directive 2001/83 state: ‘(2) The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. … (4) Trade in medicinal …
18 Jun 2009 · 62007CJ0527
Judgment of the Court (Sixth Chamber) of 15 December 2016. LEK Farmacevtska Družba d.d. v Republika Slovenija.Decision
Recitals 2 to 5 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67), as amended by Directive 2011/62/EU of the …
15 Dec 2016 · 62015CJ0700
Opinion of Advocate General Bobek delivered on 7 December 2017. Proceedings brought by Astellas Pharma GmbH.Decision
In sum, the genuine operation of the decentralised procedure, despite it forming part of a regime heralded as an ‘important step towards achievement of the objective of the free movement of medicinal products’, [Recital 14 of the …
7 Dec 2017 · 62016CC0557
Opinion of Advocate General Jääskinen delivered on 29 September 2011. European Commission v Republic of Poland.Decision
The aim of Directive 2001/83 is to safeguard public health as well as to ensure that trade is not affected in the market for medicinal products. [Recitals 2 to 4.] In my view, the harmonised marketing authorisation procedure is a …
29 Sep 2011 · 62010CC0185
Opinion of Advocate General Trstenjak delivered on 21 June 2007. Commission of the European Communities v Federal Republic of Germany.Decision
Recitals 2 to 5 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use state: The essential aim of any rules governing the production, …
21 Jun 2007 · 62005CC0319